Class I and II major histocompatibility complex gene product expression by a rat insulinoma cell line in vitro following exposure to gamma interferon

Abstract

A study of Class I and II major histocompatibility complex gene product expression by a rat insulinoma cell line (RINm5F) was performed using monoclonal antibodies and immunoperoxidase techniques. RINm5F cells were incubated with different concentrations of gamma interferon. RINm5F cells exhibit low levels of Class I molecules and are normally devoid of Class II gene products. Upon exposure to gamma interferon, RINm5F cells showed a dramatic increase in Class I expression. This expression was homogenous and could be detected on all cells after 18 h of incubation with as little as 1 unit/ml of interferon. In contrast, de novo Class II expression was not homogeneous and required 36 h of incubation with 10 units/ml of interferon. The number of RINm5F cells expressing Class II antigens was dose- and time-dependent. Interferon treatment did not affect the morphology of RINm5F cells as determined by ultrastructural analysis. Withdrawal of interferon from the culture medium for as long as 78 h diminished but did not abolish the expression of Class I and Class II molecules already induced. The ability of interferon to enhance expression of Class I gene products and induce de novo expression of Class II molecules on B-cell-derived RINm5F cells supports the hypothesis that aberrant expression of major histocompatibility complex gene products on pancreatic B cells may be an important factor in triggering the immune response in Type 1 (insulin dependent) diabetes mellitus.

Modulation of NKT Cell Development by B7-CD28 Interaction: An Expanding Horizon for Costimulation

“…To exclude the effect of weak costimulatory signaling from B7 mutant antigen presenting cells [47], both purified CD4 T cells from WT and B7KO mice was stimulated in vitro with purified CD11c+ dendritic cells from WT mice. As shown in Fig.…”

Founders of Pediatric Pathology: Thomas A. Seemayer

“…The initial report on infantile graft-versus-host disease [13] led to years (1976–2002) of research with Dr Lapp [14,15]. Studies on the “BB” Wistar rat, an excellent model of type I, insulin-dependent diabetes mellitus, were conducted with Dr Colle over 10 years at the Montreal Children's Hospital [16,17]. The stroma of many invasive and metastatic carcinomas, especially tumors featuring retraction and desmoplasia, is replete with myofibroblasts [18].…”